The anticancer activity of the N-terminal CARD-like domain of arginine deiminase (ADI) from Pseudomonas aeruginosa

Madhuchhanda Kundu, Johnson Thomas, Arsenio M. Fialho, Jennifer M. Kwan, Leonilde M. Moreira, Magdy Mahfouz, Tapas K. Das Gupta, Ananda M. Chakrabarty

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

While arginine deiminase (ADI) from Mycoplasma arginini is a well-known anticancer agent, very little is known about any such role of ADI from other bacteria. Additionally, M. arginini ADI is believed to exert its anticancer activity due to depletion of arginine from cancer cells. In this report, we demonstrate anticancer activity of ADI from Pseudomonas aeruginosa. We have also cloned and expressed a truncated form from the P. aeruginosa ADI which harbors a caspase recruitment domain (CARD). This polypeptide, called Pa-CARD, demonstrates anticancer activity without exhibiting any ADI enzymatic activity by inducing apoptosis in cancer cells but not in normal cells. Microarray experiments suggest that Pa-CARD modulates NF-kB signaling pathway genes to exert its anticancer activity.

Original languageEnglish (US)
Pages (from-to)403-412
Number of pages10
JournalLetters in Drug Design and Discovery
Volume6
Issue number6
DOIs
StatePublished - Sep 2009

Keywords

  • Anticancer agents
  • Arginine deiminase (ADI)
  • Azurin
  • CARD domain
  • Pseudomonas aeruginosa

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine
  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'The anticancer activity of the N-terminal CARD-like domain of arginine deiminase (ADI) from Pseudomonas aeruginosa'. Together they form a unique fingerprint.

Cite this